Latest Regulatory Approvals News

Orion Minerals has secured $15.4 million in a placement to accelerate development at its Prieska and Okiep copper projects in South Africa, paving the way for its transition to a copper producer.

Codan Limited is acquiring the intellectual property of US-based Adaptive Dynamics to enhance its electronic warfare and mission-critical communications capabilities, aiming to strengthen its position in next-generation defence programs.

Godolphin Resources is spinning out its Narraburra Rare Earths Project into a new ASX-listed entity, Matrix Critical Minerals, with MST Financial appointed to spearhead the IPO expected in the second half of 2026.

White Energy has inked a non-binding term sheet to acquire coal assets in Alabama and Queensland, backed by a $15 million capital raise and planned board reshuffle.

Rapid Critical Metals has kicked off drilling at its flagship Webbs Silver Project in New South Wales while securing additional prospective ground through a new exploration licence application, aiming to grow its district-scale silver portfolio.

PMET Resources has kicked off a substantial 45,000-meter drilling program at its flagship Shaakichiuwaanaan Property in Quebec, aiming to bolster lithium, caesium, and tantalum resource development ahead of updated economic studies.

Avecho Biotechnology has wrapped up the treatment phase for its pivotal Phase III insomnia trial involving 244 participants, setting the stage for an interim efficacy analysis expected in late June 2026.

Brightstar Resources is poised to hit a major milestone with a Final Investment Decision expected in June 2026, paving the way for first gold production by mid-2027 at its Goldfields Project in Western Australia.

Viking Mines has uncovered additional tungsten mineralisation in historical stockpiles near the Conquest mine at its Linka Project in Nevada, with ore sorting testwork underway and maiden drilling set for late June.

Comet Ridge has revised its acquisition deal for Santos’ stake in the Mahalo Gas Project, cutting upfront cash and extending deadlines to navigate new government gas reservation policy uncertainty.

Elanor Investors Group has obtained an ASX waiver allowing it to delay issuing stapled securities as part of its acquisition of Singapore-based Firmus Capital until July 10, 2026, due to pending regulatory approvals.

Argenica Therapeutics has passed a critical FDA genotoxicity test for its stroke drug ARG-007, advancing its IND application and edging closer to Phase 2b clinical trials in the US and Australia.